ShockWave Medical Inc. (SWAV)
NASDAQ: SWAV
· Real-Time Price · USD
334.75
-0.08 (-0.02%)
At close: May 30, 2024, 10:00 PM
ShockWave Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 218.81M | 202.98M | 186.02M | 180.16M | 161.07M | 144.03M | 131.33M | 120.75M | 93.63M | 84.18M | 65.16M | 55.91M | 31.9M |
Cost of Revenue | 28.21M | 25.32M | 24.51M | 24.49M | 21.07M | 17.5M | 17.87M | 16.73M | 12.89M | 12.66M | 10.95M | 9.93M | 7.89M |
Gross Profit | 190.6M | 177.66M | 161.51M | 155.67M | 140M | 126.52M | 113.46M | 104.02M | 80.74M | 71.52M | 54.21M | 45.97M | 24.01M |
Operating Income | 42.41M | 44.58M | 43.62M | 32.37M | 39.81M | 42.42M | 36.76M | 29.58M | 15.37M | 13.98M | 2.81M | -180K | -17.49M |
Interest Income | 12.32M | n/a | 2.51M | 810K | 636K | 969K | 316K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 50M | 55.46M | 45.08M | 33M | 40.74M | 44.65M | 35.12M | 26.34M | 14.72M | 13.05M | 2.03M | -352K | -23.56M |
Net Income | 55.35M | 44.3M | 34.99M | 28.86M | 39.13M | 140.91M | 35M | 25.56M | 14.52M | 12.94M | 1.95M | -425K | -23.6M |
Selling & General & Admin | 103.72M | 92.06M | 78.36M | 86.47M | 73.22M | 60.38M | 56.52M | 53.68M | 48.35M | 42.82M | 37.66M | 34.34M | 31.22M |
Research & Development | 44.47M | 42.32M | 39.53M | 36.83M | 26.97M | 23.72M | 20.18M | 20.76M | 17.02M | 14.72M | 13.73M | 11.81M | 10.28M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -310K | -213K | -280K | 146K | -235K |
Operating Expenses | 148.19M | 133.08M | 117.88M | 123.3M | 100.19M | 84.1M | 76.69M | 74.44M | 65.37M | 57.54M | 51.39M | 46.15M | 41.49M |
Interest Expense | 2.94M | 2.95M | 2.51M | 810K | 636K | 969K | 316K | 304K | 297K | 301K | 165K | 318K | 312K |
Selling & Marketing Expenses | 74.49M | 67.18M | 56.91M | 56.74M | 54.01M | 43.44M | 42.08M | 40.52M | 35.96M | 33.19M | 28.39M | 25.71M | 23.99M |
Cost & Expenses | 176.4M | 158.4M | 142.4M | 147.79M | 121.25M | 101.6M | 94.57M | 91.17M | 78.26M | 70.2M | 62.34M | 56.09M | 49.39M |
Income Tax Expense | -5.35M | 11.15M | 10.09M | 4.14M | 1.61M | -96.26M | 118K | 774K | 197K | 106K | 78K | 73K | 44K |
Shares Outstanding (Basic) | 37.28M | 36.93M | 36.8M | 36.66M | 36.43M | 36.18M | 37.95M | 35.83M | 37.23M | 35.35M | 35.21M | 35.03M | 34.71M |
Shares Outstanding (Diluted) | 38.47M | 38.16M | 38.2M | 38.23M | 37.98M | 37.99M | 37.95M | 37.69M | 37.62M | 37.61M | 37.57M | 35.03M | 34.8M |
EPS (Basic) | 1.48 | 1.20 | 0.95 | 0.79 | 1.07 | 3.89 | 0.92 | 0.71 | 0.39 | 0.37 | 0.06 | -0.01 | -0.68 |
EPS (Diluted) | 1.44 | 1.16 | 0.92 | 0.76 | 1.03 | 3.71 | 0.92 | 0.68 | 0.39 | 0.34 | 0.05 | -0.01 | -0.68 |
EBITDA | 56.05M | 47.66M | 50.6M | 33.81M | 41.37M | 47.16M | 36.7M | 27.75M | 16.73M | 15.02M | 3.67M | 437K | -22.12M |
EBIT | 52.94M | 58.41M | 47.59M | 33.81M | 41.37M | 45.62M | 35.44M | 26.64M | 15.02M | 13.35M | 2.19M | -34K | -23.25M |
Depreciation & Amortization | 3.11M | 3.08M | 3.01M | 2.57M | 1.56M | 3.2M | -1.33M | -2.6M | 1.36M | 1.67M | 1.48M | 1.26M | 1.13M |